Command Palette

Search for a command to run...

Clinical Trials · NCT02408705

Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects

CompletedPhase 2Liraglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Medical University of Graz
Enrollment
14
Start date
Jan 2015
Locations
1 site, Austria
Primary endpoint
Area under the curve of the endogenous glucose production from (=EGP) from begin of the hypoglycaemic clamp 5.5 mmol/L period until the end of recovery period (4.0 mmol/L), calculated from stable isotope labelled plasma glucose
View Liraglutide compound reference